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Medication reconciliation is defined by the American Society of Health- System 
Pharmacists (ASHP) and the American Pharmacists Association (AphA) as “the 
comprehensive evaluation of a patient’s medication regimen any time there is a 
change in therapy in an effort to avoid medication errors such as omissions, 
duplications, dosing errors or drug interactions, as well as to observe compliance 
and adherence patterns “. 
Medication reconciliation is very important to avoid medication errors but it is also 
a complex and time-consuming process. Medication histories, i.e. records of 
prescription, purchase, and refill sequences are considered to be a resource from 
which conclusions about medication reconciliation can be drawn. However, 
medication histories spread across diverse paper and electronic media may lack 
the required accuracy. By employing multiple electronic sources this thesis will 
evaluate if more accurate medication histories can be collected.  
To find out how the process of obtaining accurate and complete medication 
histories can be less time consuming, different medication history sources were 
analyzed. 
The aim was to determine discrepancies between these medication history 
sources, what the reasons are and to find a way to avoid them. Furthermore 
identifying the unintentional medication discrepancies and prevent potential harm. 
Therefore two different scenarios were implemented for four different medication 
history sources. First, patient-interview data, EMR and discharge records and the 
Blue Cross Blue Shield insurance claims data were compared and the second 
scenario compared patient-interview data, EMR and discharge records with the 
Tufts-Healthplan database.  
It turned out that the most discrepancies are system-generated errors and also 
and the majority of them ensued from discontinued or expired medications that 
had been pursued on the medication list.  
In the first scenario there were in total 1251 records and 570 discrepancies 
regarding these medication records for 14 individual patients. In the second case 
there were 660 medication records including 267 discrepancies in total for nine 
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1 Introduction 
1. Introduction  
 
Medication reconciliation is a national patient safety goal, but its effects on 
important patient outcomes require further evaluation. The Joint Commission on 
Accreditation of Healthcare Organizations has defined the medication 
reconciliation as a “national patient safety” because medication discrepancies are 
a contributor to adverse drug events (ADEs) [Pippins JR, MD et al, 2008] and have 
the potential to cause harm. Discrepancies may have clinically significant 
consequences, especially in the elderly population. [Steurbaut S, et al., 2010]. This 
shows that medication reconciliation is the fundament of the healthcare but no 
method has been recommended yet. To improve the quality and safety in 
healthcare unintentional medication discrepancies, which are specified as 
differences between medication history sources should be considered.  
More than a quarter of the prescribing errors in hospitals at the time of admission 
are ascribable to incomplete medication histories. The most common medication 
reconciliation errors are attributable to omitted medications and doses [Warholak 
TL et al., 2009].  Previous studies evaluating medication reconciliation have shown 
that discrepancies are common, since up to 67% of inpatients have at least 1 
unexplained discrepancy in their prescription medication history at admission 
[Schnipper JL et al., 2009]. 
Clinical pharmacists are convenient to acquire medication histories for patients 
and also to identify discrepancies and problems regarding medications. This 
should bring down adverse drug events but this process poses a large burden on 
pharmacist resources and leads to question if the involvement of pharmacists in 
this process is recommended. Enabling them to take a more complete and 
accurate medication history should give pharmacists more possibilities in direct 
patient care. Patient safety and pharmacy practice could be improved by 
enhancing electronic medication reconciliation. With the aid of revised electronic 
medication reconciliation it should be easier to collect a more accurate medication 
history. Earlier studies have shown that information technology is helpful in the 
process of taking medication histories by providing access to integrated networks 
of retail pharmacies, pharmacy benefit managers (PBMs) and health plans. All 
healthcare organizations want to relieve the burden of medication reconciliation 
while being able to meet the requirements of the Office of the National Coordinator 
(ONC) which were published in the Meaningful Use Criteria and which claim 




This thesis is going to compare three different medication history sources and find 
out discrepancies between these sources and try to define reasons for the 
discrepancies. Previous studies have already compared medication history 
sources but none of them compared three sources, for example the recent study 
by Warholak, et al. compared medication histories which were acquired through 
patient interviews upon hospital admission with the medication history source 
obtained from health plan claims data. It resulted in more information in the claims 
database than in the patient interview database. Orrico, et al. also had a study 
comparing and categorizing medication discrepancies between the medications 
recorded in the electronic medical record (EMR) with medication history database 
obtained through patient interviews at admission. The most discrepancies in this 
case were listed in the EMR and those discrepancies resulted from medications 
that were still listed in the EMR although they were no longer taken by the patient.  
 
In this thesis I will quantify and categorize the medication discrepancies that exist 
between medications that are listed in the ambulatory EMR and discharge records 
versus those obtained from two insurance claims databases versus those acquired 
from patient-interview. 
This is a retrospective study comparing these three mechanisms which serve 
medication history information about a patient at the time of admission. The 
patient-interview data which was available was collected by trained pharmacists 
using extensive medication reconciliation procedures. Medications from the EMR 
and discharge records were available from a fully electronic medication 
reconciliation tool, called the Pre-Admission Medication List (PAML) Builder. The 
insurance claims databases were provided by the TUFTS Healthplan and Blue 













In order to determine the discrepancies between medication history sources 
regarding dose, route and frequency and to find out if utilizing electronic data 
sources can enhance the process of taking medication histories, three different 
mechanisms of obtaining medication history information for a patient upon 
admission were used. 
 In the following these 3 mechanisms, a gold standard medication history, 
medication histories from a fully electronic medication reconciliation tool and the 
external data from pharmacy claims, are going to be elucidated. 
Efforts to improve the quality and safety of health care include attention to 
unintentional medication discrepancies because medication discrepancies are an 
important contributor to adverse drug events (ADEs) [Pippins JR, MD et al, 2008]. 
This chapter will explain how the sources were appointed to fulfill the aim of 





2.1.1. Partners Medication Reconciliation (PMR) Study 
 
In a previous study a gold standard medication history was collected by trained 
pharmacists, which used medication reconciliation methods.  
In this study called Partners Medication Reconciliation (PMR) Study, trained 
clinical pharmacists collected gold standard medication histories of patients by 
using all available sources of medication information: patient, family, pill bottles 
and/or medication lists from home, the outpatient medical record, previous 
discharge summaries, the primary care provider or other doctor’s office, and the 
community pharmacy.  
It was a cluster-randomized controlled trial, on medical inpatients at 2 academic 
hospitals, Brigham and Women`s Hospital (BWH) and Massachusetts General 
Hospital (MGH) from May to June 2006 in Boston, Massachusetts. The PMR study 
attempted to measure the impact of an information technology-based medication 
reconciliation intervention on medication discrepancies with potential for adverse 
drug events (PADEs) [Schnipper JL et al., 2009]. 
Therefore 322 patients were admitted to 14 medical teams, involving physicians, 
nurses, and pharmacists and a computerized tool supporting medication 
reconciliation. 
The medication history of those patients, who were general medical patients, was 
taken before discharge. 
The gold standard medication history taken by study pharmacists was compared 
with medication histories of medical teams, admission and discharge orders. 
The main outcome of this study was the amount of unintentional discrepancies 
between preadmission medication and admission or discharge medications which 
had potential for harm (PADEs) [Schnipper JL et al., 2009]. 
This study provided the gold standard medication history which was used for 




2.1.2. Electronic Medication Reconciliation at Partners Healthcare 
 
At Partners Healthcare there is a fully electronic, inpatient medication 
reconciliation tool, which is called the Pre-Admission Medication List (PAML) 
Builder. It is an application with access to outpatient Electronic Medication 
Records (EMR) and discharge records.  
 It is a web-based application that promotes the creation of a preadmission 
medication list from several electronic sources and it is responsible for extracting a 
patient’s medication data from inpatient and outpatient medication sources.  
Those medication sources are including Longitudinal Medication Records (LMR), 
ambulatory EMR and medication discharge information from the computer 
provider order entry (CPOE) at the 2 academic medication centers from Partners, 
the Brigham and Women`s Hospital (BWH) and the Massachusetts General 
Hospital (MGH). 
The PAML Builder documents a planned action on admission for each PAML 
medication and facilitates review of a completed PAML and admission medication. 
It also facilitates the reconciliation of the PAML with current inpatient medication 
when discharge orders are written. 
 As the medication reconciliation takes place at time of admission the PAML- 
Builder collects 18 months of data prior to the date of admission. 
Each PAML corresponds to an individual admission event and contains 
information regarding patient demographics, medication brandname, generic 
name, therapeutic class, dose, route, frequency, dosage for, medication 
instructions etc. 
In order to complete medication reconciliation at the time of admission and 
accommodate the PAML with admission orders, users are required to enter a 
planned action on admission for each medication record on the PAML [Turchin A 
et al., 2008] 






2.1.3. Medication data from insurance claims 
 
The external data used in this thesis was the pharmacy claims information. 
To get access to pharmacy claims data from two of the largest health plans in 
Massachusetts: Blue Cross Blue Shields and Tufts Health Plan the SureScripts 
integrated network was used. Partners Healthcare uses a regional healthcare 
information (RHIO) called MA-SHARE [Massachusetts SHARE (Simplifying 
Healthcare Among Regional Entities)] for inter-organizational exchange of 
healthcare data. MA-SHARE sends a patient query to SureScripts which extracts 
claims data for Blue Cross Blue Shields (BCBS) and Tufts Health Plan. The data 
used in this thesis for pharmacy claims data was received from MA-SHARE 
through pre-established secure electronic prescribing connectivity on the research 
sever of Partners Healthcare.  
Data for the patients from the PMR Study who were enrolled in these health plans 
during the dates of October 15, 2007 through Feb 15, 2008 were used.  
Providing access to integrated networks of retail pharmacies, pharmacy benefit 
managers (PBMs) and health planes can ease the process of taking medication 
histories. This also offers an additional source of medication history information to 
improve the process of medication reconciliation and was used as the third 





To be able to compare the different medication history sources they were provided 
as individual databases. Altogether I was allocated four databases.  
 
2.2.1. Gold Standard Medication History Database 
In total there are 1790 records in this database. The following table is just 
showing a small extract out of this database. 
 
medhistorycaseid medname DRF PRN OTC ... 
1034 protonix 40 mg BID FALSE FALSE ... 
1034 Folic acid 1 mg PO 
QD 
FALSE FALSE ... 
... ...    ... 
Figure 1: Extract Gold standard medication history database 
Figure 1 is an extract out of the gold standard medication history database and 
there are in total 44 attributes in this database but in the final spreadsheet which 
was used to find out the discrepancies only three attributes were needed, the 
medicationHistoryCaseID, medication name and DRF (dose, route, frequency). 
Comparisons showed that there are 178 individual patients in the gold standard 
medication history database. 
2.2.2. Pre- Admission Medication List Database 
 
recordid MedHistoryCaseID PAML MRecSource factaudit Seq dose doseunits ... 
5630248 1001 1158776 Discharge F 4 20 MG ... 
5630245 1001 1158776 Discharge F 1 325 MG ... 
5630246 1001 1158776 Discharge F 2 75 MG ... 
5630247 1001 1158776 Discharge F 3 100 MG ... 
... ... 
      
... 
         
Figure 2: Extract PAML- database 
 
The amount of all records in PAML-Builder database seen in Figure 2 is 530086 
and much more than in the other databases. Out of 58 different attributes only 
seven were used to find out differences the medicationHistoryCaseID, medication 
 
8 Methods 
name, generic name, dose, dose units, route and frequency. 17074 individual 
patients are included in this database.  
2.2.3. Blue Cross Blue Shield Database 
 
medhistorycaseId CLIENT_NAME DIV BPL GRP CONTRACT_NO DRUG_NAME ... 
328724 
BCBS OF 
MASSACHUSETTS MDX 50126 3108 8419391 
LEVOXYL 75 
MCG TABLET ... 
328724 
BCBS OF 
MASSACHUSETTS MDX 50126 3108 8419391 
LEVOXYL 75 
MCG TABLET ... 
... ... ... 
    
... 
        
Figure 3: Extract Blue Cross Blue Shield database 
 
With 155778 records, the Blue Cross Blue Shield database from which an extract 
can be seen in Figure 3 was the second biggest database. The Blue Cross Blue 
Shield database includes 36 attributes and during the analysis five of them were 
needed. In this case the medicationHistoryCaseID was used again and the drug 
name. 155778 records included 1967 individual patients. 
2.2.4. Tufts Health Plan Database  
 
Medhistorycaseid Date_of_Fill Drug_name Drug_strength DoseFormAbbreviation ... 
187550 07-Mai-10 
DESMOPRESSIN 
ACETATE 0.2MG TAB ... 
187550 07-Mai-10 HYDROCORTISONE 5MG TAB ... 
... ... 
   
... 
      
Figure 4: Extract Tufts Health Plan database 
 
The tufts health plan database seen in figure 4 has 43371 total medication records 
and 15 different attributes. Six out of 15 attributes were listed in the final 
spreadsheet which was used to compare the databases regarding discrepancies. 
MedicationHistoryCaseID, drug name, drug strength, dose form abbreviation 




As for the insurance claims databases, bcbs and tufts health plan, which do not 
contain information about the frequency, the frequency had to be inferred by 
dividing the “Quantity Dispensed” by “Days’ Supply.” 







20 5 4 
Figure 5: Example 
 
In a medication record 20 tablets were dispensed for a period of five days, this 
means that the frequency is four times a day. 
2.3. Analysis 
 
In this section the methods used to find out the discrepancies are explained. 
First of all the mentioned databases were analyzed for which information they 
included and which could be expedient for the determination of discrepancies.  
Among those databases there were many differences regarding the information, 
so the most useful contents out of the databases were aggregated to queries 
which were made to spreadsheets.  
Whereas, two different medication history sources from insurance claims were 
provided, the Blue Cross Blue Shield Database and the Tufts Health Plan 
Database, two spreadsheets were needed. 
The first spreadsheet contained information from three databases, gold standard 
medication history database, pre-admission medication list database and blue 
cross blue shield database. In the second spreadsheet there was information from 
gold standard medication history database, pre-admission medication list 
database and from the health plan database. 
To obtain the most useful contents out of the databases I joined the medication 
history case ID´s with SQL commands in Microsoft Access. To get to know MS 
Access I had to participate in a MS Access web-based Training called “Get to 




SQL Command for the first spreadsheet as follows: 
 
Query for extracting the med name and DRF from BCBS: 
SELECT DISTINCT dbo_medhistorybcbs.medhistorycaseId, 
dbo_medhistorybcbs.DRUG_NAME, dbo_medhistorybcbs.STRENGTH, 
dbo_medhistorybcbs.QTY, dbo_medhistorybcbs.DAYS_SUPPLY 
FROM (dbo_medhistorybcbs INNER JOIN dbo_medhistorypamlmeds ON 
dbo_medhistorybcbs.medhistorycaseId = 








Query for extracting the med name and DRF from PAML: 




FROM (dbo_medhistorybcbs INNER JOIN dbo_medhistorypamlmeds ON 
dbo_medhistorybcbs.medhistorycaseId = 










Query for extracting the med name and DRF from Gold Standard Medication 
History: 





FROM (dbo_medhistorybcbs INNER JOIN dbo_medhistorypamlmeds ON 
dbo_medhistorybcbs.medhistorycaseId = 











Second spreadsheet:  
 
Query for extracting the med name and DRF from TUFTS: 




FROM (dbo_medhistorytufts INNER JOIN dbo_medhistorypamlmeds ON 
dbo_medhistorytufts.Medhistorycaseid = 




WHERE (((dbo_medhistorytufts.Medhistorycaseid) In (194249, 118019, 99539, 
350207, 256058, 381623, 460988, 193721, 220088))); 
 
Query for extracting the med name and DRF from PAML (tufts): 




FROM (dbo_medhistorytufts INNER JOIN dbo_medhistorypamlmeds ON 
dbo_medhistorytufts.Medhistorycaseid = 











Query for extracting the med name and DRF from Schnipper (tufts): 





FROM (dbo_medhistorytufts INNER JOIN dbo_medhistorypamlmeds ON 
dbo_medhistorytufts.Medhistorycaseid = 













Finally having the spreadsheets I started comparing them regarding any 
discrepancies in medication name, route, dose and frequency.  
Out of the discrepancies new spreadsheets were made called medication in all 
three sources, medication in two sources and medication in only one source. 
They were quantified and categorized regarding the number and type of 
medication discrepancies that exist between medications reconciled using the 
spreadsheets. 
To make this process of obtaining discrepancies easier it was the best to mark the 
same medication records for the same medication history case IDs in the same 
color to see the discrepancies at first sight. Some of those color-coded 
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3. Results and Findings 
 
In this chapter the results of this thesis are going to be explained. First the amount 
of individual patients in the databases is going to be listed for both scenarios, and 
then the results for both scenarios are going to be explained separately.  
In 3.1 the results for the first scenario comparing PAML, Gold Standard medication 
list and BCBS is outlined starting with the amount of individual patients listed in at 
least two sources. Additionally the number of medication records for individual 
patients and then the discrepancies which occur in one source, in two sources or 
in all three sources are going to be shown.  
In 3.2 the same process like in 3.1 is going to be run for PAML, Gold Standard 






















Table 1: Individual Patients in Databases 
 
During the process analyzing the databases the first thing which occurs is that 
there are differences in the amount of individual patients in every database. Like 
shown in Table 1, there are 17074 individual patients in the Pre-Admission 
Medication List Database whereas there are only 178 individual patients in the 
gold standard medication history database. 
Comparing the amount of individual patients in the insurance claims databases it 
is conspicuous that there is such a huge difference, while Blue Cross Blue Shield 
contains 1967 individual patients Tufts Health Plan only contains 632 individual 
patients.  
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3.1. Results regarding BCBS, PAML and GOLD STANDARD    
 Medication History Sources  
 
 
BCBS + PAML +  GOLD STANDARD 
 
14 patients who had med hx in all three 
sources 
 
BCBS + PAML 
 
1867 patients  had med hx in 2 sources  
 
BCBS + GOLD STANDARD 
 
14 patients  
Table 2: Patients in at least 2 sources 
 
In the process of determination it turned out to 14 individual patients which were in 
all three medication history sources, BCBS, PAML and Gold Standard medication 
histories like seen in Table 2. The focus was on these 14 patients and their 
medication histories.  
Extracting medication name, dose, route and frequency from those three sources 
resulted in the table below. 
 
BCBS 704 medication records (14 patients)  




133 records (14 patients) 
Table 3: Extracting medname +DRF from BCBS,PAML GOLD   STANDARD  
 
Table 3 shows that there are already discrepancies in the amount of medication 
records because 704 medication records for 14 individual patients in BCBS is a 
huge difference to only 414 records in PAML or 133 medication records for the 
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Medication records in only one medication history source:  
369 records (each record indicates a medication record but may not indicate an 
individual medication) only in one source either in PAML, GOLD STANDARD or 
BCBS:  
 











42812 MI 1 12 13 
51491 5 MI 33 38 
87329 3 MI 2 5 
140294 9 1 18 28 
190223 18 1 9 28 
285527 5 MI 27 32 
292325 5 MI 13 18 
295031 13 1 12 26 
377564 6 1 20 27 
399212 4 MI 8 12 
487817 8 1 30 39 
514349 6 MI 19 25 
545963 14 MI 32 46 
548273 16 8 8 32 
SUM 112 14 243 ∑ 369 
Table 4: Discrepancies of records only in one medication history source 
 
Table 4 indicates that there are in total 112 medication records which are only 
listed in the PAML database, 14 of them are only in the Gold Standard medication 
history database, 243 of medication records are only included in BCBS database 
for 14 individual patients. 
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42812 7 1 1 MI 3 
51491 8 2 4 MI 3 
87329 1 - 1 MI - 
140294 9 3 5 MI 2 
190223 4 1 MI, 1 3 MI 1 MI, 1 
285527 6 1 3 MI 2 
292325 6 1 MI, 2 1 MI 1 
295031 10 1 7 MI 2 
377564 8 2 3 MI 3 
399212 7 1 MI, 1 2 MI 1 MI, 1 
487817 22 2 MI, 5 6 MI, 1 9 
514349 8 2 MI 5 MI 2 
545963 14 1 MI, 2 9 MI 1 MI, 4 
548273 19 1 MI, 1 5 MI 5 
SUM 129 31 55 41 
Table 5: Discrepancies of records only in two medication history sources 
 
Within 14 individual patients, whose records are at least in two medication history 
sources, this means in PAML, GOLD STANDARD or BCBS, there are in total 129 
medication records like seen Table 5. Each of these records indicates a 
medication record but doesn’t have to be individual medications. 
Also in this case there are a lot of discrepancies especially regarding the route, 
which ends up with 55 differences. Most of the discrepancies arise as missing 
information but this also means a difference to the other medication history 
sources.   
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In-Depth analysis of the spreadsheet it resulted in the table shown below: 
 












42812 6 2 6 MI 2 
51491 1 - 1 MI - 
87329 3 - 3 MI - 
140294 7 1 4 MI 1 
190223 3 1 - - 
285527 1 1 1 MI - 
292325 - - - - 
295031 5 - 5 MI 2 
377564 4 1 MI, 3 2 MI 3 
399212 3 - 3 MI 1 
487817 6 3 5 MI 4 
514349 5 3 4 MI 2 
545963 7 1 MI 7 MI 2 
548273 1 - - - 
Sum 52 16 41 17 
Table 6: Discrepancies in all three sources BCBS, PAML, GOLD STANDARD 
  
Table 6 shows the individual patients based on their medication history case IDs, 
their total medications in all medication history sources and the amount of 
discrepancies regarding dose, route and frequency.  
It is conspicuous that there is one patient with the medication history case ID 
292325, who doesn’t have any medications listed in his records, which is in all 
sources. As appears from the table, there are in total 52 medication records for 14 
individual patients and in total 74 discrepancies regarding dose, route and 
frequency when aggregated. This means there are more discrepancies than 
medication records. Comparing the discrepancies you can see the most 
discrepancies are in the route, because there is much missing information (MI) 
about the route in the sources.  
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3.1.1. Results regarding BCBS, PAML and GOLD STANDARD 
Medication History Sources 
 
All in all the results show that there are lots of discrepancies regarding dose, route 
and frequency and also regarding the medication name. 
In-depth analysis there are 369 records which are only in one source, 129 records 
in two sources and only 52 records are in all three sources for 14 individual 
patients.  
This means 369 plus 129 discrepancies regarding the medication record, because 
those medication records are only included in one or two sources. 
The result tables show lots of missing information which also should be seen as 
discrepancies, because they could be indicators for adverse drug events. 
The next step in the analysis was like already described in the methods section 
the discussion why there are so many discrepancies and what is the main reason 
for them? The answer to this question follows in the reasons section of this 
chapter  
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3.2. Results regarding TUFTS, PAML and GOLD STANDARD 
 Medication History Sources 
 
TUFTS + PAML +  GOLD STANDARD 9 (8+1) patients 
TUFTS  + PAML 632 patients 
TUFTS  + GOLD STANDARD 9 patients  
Table 7: Patients in at least 2 sources 
 
In this case like seen in Table 7 there are only 9 individual patients which are in all 
three sources, so the focus was on these 9 patients and their information about 
medication name, dose, route and frequency as follows:  
TUFTS 271 records (9 patients)  
PAML 290 records ( 9 patients)  
GOLD STANDARD 99 records (9 patients)  
Table 8: Extracting medname + DRF from TUFTS, PAML, GOLD STANDARD 
 
 Also Table 8 makes clear, that there are discrepancies in the medication records, 
because there are 290 medication records for 9 patients whereas there are only 
99 records for the same 9 patients.  
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Medication records in only one medication history source:  
179 records only in one source either in PAML, GOLD STANDARD or TUFTS:  
 












99539 MI MI 11 11 
118019 18 3 18 39 
193721 8 MI 5 13 
194249 8 1 2 11 
220088 2 1 11 14 
256058 6 5 5 16 
350207 25 2 21 48 
381623 5 MI 7 12 
460988 3 1 11 15 
SUM 75 13 91 ∑ 179 
Table 9: Discrepancies of records only in one medication history source 
 
Among nine individual patients in total 179 medication records are only available in 
one source, either in PAML, Gold Standard medication list or Tufts Health Plan. As 
one can see in Table 9 out of 179 medication records 75 are only in PAML, 13 
only included in GOLD STANDARD medication list and 91 only included in TUFTS 
Health Plan.   
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Medication records in two sources PAML, GOLD STANDARD, TUFTS  
 










99539 - - - - 
118019 13 3 1 MI 4 
193721 5 1 MI 4 MI 1 MI, 1 
194249 2 1 - 1 
220088 9 - 2 MI 2 
256058 6 1 MI , 1 - 3 
350207 14 1 MI, 2 8 MI, 1 1 MI, 4 
381623 2 - 1 MI - 
460988 6 2 1 MI 2 
SUM 57 12 18 19 
Table 10: Discrepancies of records only in two medication history sources 
 
Table 10 shows that altogether there are 57 medication records in at least two of 
the medication history sources, PAML, GOLD STANDARD and TUFTS for 9 
individual patients. 
Among 57 medication records, 12 discrepancies in dose, 18 in route and 19 
regarding frequency, are existing.   
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In the table below all medication records, which are listed in all three sources 
PAML, GOLD STANDARD and TUFTS medication histories are shown: 
 










99539 - - - - 
118019 7 3 - 4 
193721 5 - 3 MI 3 
194249 2 2 1 MI 2 
220088 8 2 2 MI 3 
256058 6 1 1 MI 2 
350207 - - - - 
381623 4 1 MI, 1 2 MI 1 
460988 7 2 - 3 
Sum 39 12 9 18 
Table 11: Discrepancies in all three sources TUFTS, PAML, GOLD STANDARD 
 
In two cases, there are no medication records for those two patients which are in 
all three sources. Like one can see in Table 11 in total there are 39 medication 
records for 9 individual patients. Among those 39 records, there are 12 
discrepancies regarding the dose, 9 discrepancies regarding route and 18 
regarding the frequency, which is in total 39 discrepancies. 




25 Results and Findings 
3.2.1. Results regarding TUFTS, PAML and GOLD STANDARD 
Medication History Sources 
 
In this case the results are also like in the section above which described the 
results regarding the spreadsheet including BCBS, PAML and GOLD STANDARD 
medication history sources. In total there are nine individual patients which were 
analyzed thoroughly. 179 medication records only in one source, 57 records only 
in two sources and just 39 records in all three sources indicate that there must be 
lots of discrepancies and missing information. The reasons for these differences 
are discussed in the section below.  
 
3.3. Reasons for the discrepancies  
 
Previous studies have shown that 60% -67% of medication histories contain at 
least 1 error and that an estimated 11%-59% of these errors are clinically 
important.  
[Orrico KB et al., 2008]  
The most discrepancies in these studies turned out to be system-generated errors 
and the majority of the system generated discrepancies ensued from discontinued 
or expired medications that had been pursued on the medication list.  
“True inaccuracies, such as the entry into the EMR of an incorrect dose or 
frequency or the entry of a duplicate order entry, were rare.” [Orrico KB, 2008]  
Another study by Warholak, et al. employed claims data in the acute care setting 
for medication reconciliation [Warholak TL, 2009]. This study compared 
medication information obtained from patient interview upon admission to the 
history obtained electronically through health plan claims. It has shown that the 
most common medication errors are referable to omitted medications and doses.  
In this thesis there were in the first case BCBS, PAML and Gold Standard 
medication history sources in total 1251 records and 570 discrepancies regarding 
these medication records. In the second case TUFTS, PAML and Gold Standard 
medication history sources there were 660 medication records including 267 
discrepancies in total.  
The most missing information in both cases are in the claims data which could be 
seen as a hint that those medication records are missing in the TUFTS Health 
Plan and Blue Cross Blue Shield databases are over the counter medications.  
Over the counter medications are medications which do not need any prescription 
from a health care professional, as compared to prescription drugs, which only are 
sold to consumers possessing a valid prescription. Prescribed drugs are always 
listed in the claims data, so this could be a reason why there are so many missing 
medication records in the claims data. 





In this study four different medication history sources were given to compare and 
identify discrepancies between those sources. The sources were the Gold 
Standard Medication History database, PAML-Builder database, Tufts Health Plan 
database and the Blue Cross Blue Shield database. To determine discrepancies 
the most useful contents out of the databases were aggregated to queries which 
were made to spreadsheets which were used to compare the databases regarding 
the information for common patients.  Two scenarios were implemented so two 
spreadsheets with the most useful information out of the databases were 
available.  
They included a medication history case ID, medication name, dose, route and 
frequency in the first case for 14 individual patients and in the second spreadsheet 
for 9 individual patients. 
The results have shown that there are many discrepancies regarding the 
medication name, dose, route and frequency.  
For example in the first scenario there were 14 individual patients which had in 
total 550 medication records and only 52 medication records were listed in all 
three sources, BCBS, PAML and Gold Standard, which means that only 9.45 % of 
the records have no discrepancies regarding the medication name. 369 of 550 
records are listed in only in one source either in PAML, BCBS or Gold Standard 
and 129 in two sources which are in total 498 medication records which are not 
listed in all three sources and in this way they are discrepancies because they are 
missing and there is no information about a medication which is taken by a patient. 
498 discrepancies are 90.5 % out of 550 medication records which is a big amount 
that could lead to adverse drug events.   
The second scenario which was implemented it turned out to 275 total medication 
records in all three sources PAML, Gold Standard and Tufts Health Plan for nine 
individual patients. Only 14.18 % of these medications were listed in all three 
sources which mean that there were 39 medication records for nine patients 
without discrepancies regarding the name of the medication. About 86 % 
medication records are not listed in all sources and it shows that there are 236 
discrepancies concerning medication name.  
This shows that neither the PAML-Builder database nor the Gold Standard 
medication history database nor the insurance claims database present a 




While considering the results regarding dose, route and frequency in the first 
scenario the results were as follows:  
There were 36 discrepancies regarding the dose and 11 missing information about 
the dose, so in total 47 discrepancies regarding dose considering PAML-Builder, 
Gold Standard Medication List and the BCBS database.  There was one 
discrepancy regarding route and there were 96 missing information about the 
route, in total 97 discrepancies regarding route.54 discrepancies regarding 
frequency and there were two missing information about the frequency, so there 
was in total 56 discrepancies regarding frequency.  
The second scenario considering discrepancies in dose, route frequency resulted 
in 20 discrepancies regarding dose and 4 missing information, 24 in total. One 
difference and 26 missing information about route, 27 discrepancies regarding 
route and there were 35 discrepancies regarding frequency and 2 missing 
information about the frequency, which means there was in total 37 discrepancies 
regarding frequency. 
It was very difficult to find a way in which it is was possible to gather information 
about the discrepancies because there was no verified guidelines available which 
showed how to compare different medication history sources. So I had to find a 
way how to determine the existing discrepancies. Like described in the Materials 
section I used Microsoft Access to build queries and filter to most useful 
information. It was also helpful to work with color-coded spreadsheets.  
Another difficulty was to determine medications which were the same but were 
called differently. Therefore the solution was to look the medications up in some 
drug guides. Also described in the Materials section above the most medication 
discrepancies were attributable to system-generated factors.  
The limitation in this thesis was not being able to find out if the entries into the 
databases were incorrect entries in dose, route or frequency but the results show 
that if the entry into the database was an entry of incorrect information or the entry 
of a duplicate order entry, they were rare. The results show that there was more 
missing information than discrepancies which is a hint that the entries into the 
databases were incorrect in fewer cases.  
The studies from Warholak and Orrico in which two medication history sources 
were available to compare have shown that the majority of discrepancies were the 
result of discontinued medications that were still listed in the history sources long 
after the patient stopped taking those medications. These entries into the 
databases resulted in unintentional discrepancies, so you might suppose that also 
the entries which have been made into the PAML-Builder, Gold Standard 
Medication, Blue Cross Blue Shield and Tufts Health Plan databases were 





Another limitation in this thesis was not having any information about the accuracy 
of patient-interviews so it was not possible to find out if the discrepancies which 
were in the gold standard medication list accurate. If they were inaccurate those 
discrepancies were patient-generated errors. The Institute for Healthcare 
Improvement recommends encouraging patients to play a major role in keeping 
their medication lists up to date as they visit diverse providers in the outpatient 
setting. [Orrico KB et al., 2008]  
 
All in all the focus of this thesis was to analyze the medication history sources: 
gold standard medication history, PAML and insurance claims data. They were 
compared by using aggregated medication lists which included the most needed 
information about the medication name, dose, route and frequency to identify 
discrepancies and categorize them. All this work was done to use those 
information about existing discrepancies to understand the pharmacists 
perspective in taking medication history. The results of this thesis are going to be 







To make the process of obtaining discrepancies easier it was the best to mark the 
same medication records for the same medication history case IDs in the same 
color to see the discrepancies at first sight. On the following pages one of these 
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